131 related articles for article (PubMed ID: 7387830)
1. Single versus multiple human-equivalent doses of C. parvum in mice: neutralization of the anti-metastatic effect.
Mitcheson HD; Sadler TE; Castro JE
Br J Cancer; 1980 Mar; 41(3):407-14. PubMed ID: 7387830
[TBL] [Abstract][Full Text] [Related]
2. The effects of Corynebacterium parvum and surgery on the Lewis lung carcinoma and its metastases.
Sadler TE; Castro JE
Br J Surg; 1976 Apr; 63(4):292-6. PubMed ID: 1276661
[TBL] [Abstract][Full Text] [Related]
3. Radiolabelling of Corynebacterium parvum and its distribution in mice.
Sadler TE; Cramp WA; Castro JE
Br J Cancer; 1977 Mar; 35(3):357-68. PubMed ID: 851511
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of Corynebacterium parvum and retinyl palmitate used in combination on the Lewis lung carcinoma.
Pavelic ZP; Dave S; Bialkowski S; Priore RL; Greco WR
Cancer Res; 1980 Dec; 40(12):4617-21. PubMed ID: 7438095
[TBL] [Abstract][Full Text] [Related]
5. Failure of preoperative C. parvum vaccine to modify secondary disease following excision of two non-immunogenic murine carcinomas.
Hewitt HB; Blake ER
Br J Cancer; 1978 Aug; 38(2):219-23. PubMed ID: 698036
[TBL] [Abstract][Full Text] [Related]
6. Effects of amputation and Corynebacterium parvum on tumour metastases in mice.
Mosley JG; Sadler TE; Castro JE
Br J Cancer; 1978 Apr; 37(4):571-5. PubMed ID: 646927
[TBL] [Abstract][Full Text] [Related]
7. Effects of Corynebacterium parvum and cortisone on the primary Lewis tumour and its metastases.
Jones PD; Sadler TE; Castro JE
Int J Cancer; 1978 Jun; 21(6):784-8. PubMed ID: 669856
[TBL] [Abstract][Full Text] [Related]
8. The accumulated effects of repeated systemic or local injections of low doses of Corynebacterium parvum in mice.
Scott MT; Warner SL
Cancer Res; 1976 Apr; 36(4):1335-8. PubMed ID: 1083289
[TBL] [Abstract][Full Text] [Related]
9. Effects and mode of action of Corynebacterium parvum on murine tumour metastases.
Castro JE; Sadler TE; Jones PD
Dev Biol Stand; 1977 Apr 13-15; 38():277-81. PubMed ID: 608510
[TBL] [Abstract][Full Text] [Related]
10. Treatment of cancer using Corynebacterium parvum: similarity of two preparations in four animal tumor models.
Bartlett GL; Kreider JW; Purnell DM
Cancer; 1980 Aug; 46(4):685-91. PubMed ID: 7397633
[TBL] [Abstract][Full Text] [Related]
11. Effect of Corynebacterium parvum on peripheral blood platelets.
Jones PD; Sadler TE; Castro JE
Br J Cancer; 1977 Dec; 36(6):777-82. PubMed ID: 597475
[TBL] [Abstract][Full Text] [Related]
12. Effects of C. parvum on growth and induction of intracerebral tumours in mice.
Osborn DE; Sadler TE; Castro JE
Br J Cancer; 1977 Apr; 35(4):420-5. PubMed ID: 857825
[TBL] [Abstract][Full Text] [Related]
13. Lack of immunological and anti-tumour effects of orally administered Corynebacterium papvum in mice.
Sadler TE; Castro JE
Br J Cancer; 1975 Mar; 31(3):359-63. PubMed ID: 1156520
[No Abstract] [Full Text] [Related]
14. Studies with a spontaneous mouse tumor. I. Growth in normal mice and response to Corynebacterium parvum.
Woodruff MF; Whitehead VL; Speedy G
Br J Cancer; 1978 Mar; 37(3):345-55. PubMed ID: 638014
[TBL] [Abstract][Full Text] [Related]
15. Proliferative glomerulonephritis in mice given intravenous Corynebacterium parvum.
Uff JS; Mitcheson HD; Pussell BA; Brill M; Castro JE
J Pathol; 1981 Feb; 133(2):89-105. PubMed ID: 6451676
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of concomitant immunity after radiation therapy and immunotherapy in a syngeneic murine tumour system.
Deneufbourg JM
Acta Radiol Oncol; 1982; 21(5):345-8. PubMed ID: 6297254
[TBL] [Abstract][Full Text] [Related]
17. Surgery plus Corynebacterium parvum immunotherapy for Lewis lung carcinoma in mice.
Karrer K; Rella W; Goldin A
Eur J Cancer (1965); 1979 Jun; 15(6):867-73. PubMed ID: 499275
[No Abstract] [Full Text] [Related]
18. Studies on antitumor effect of corynebacterium parvum and pustulan on Lewis lung carcinoma in mice.
Budzyński W
Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):379-84. PubMed ID: 7184489
[TBL] [Abstract][Full Text] [Related]
19. Responsiveness of senescent mice to the antitumor properties of Corynebacterium parvum.
Yuhas JM; Ullrich RL
Cancer Res; 1976 Jan; 36(1):161-6. PubMed ID: 1247995
[TBL] [Abstract][Full Text] [Related]
20. Alteration in natural defense activity against NK-susceptible B16 melanoma cells after treatment with Corynebacterium parvum.
Karashima A; Taniguchi K; Yoshikai Y; Nomoto K
Immunobiology; 1991 Aug; 182(5):414-24. PubMed ID: 1916884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
